
The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor ...
Introduction Immune checkpoint inhibitors (ICIs) have demonstrated significant therapeutic efficacy across multiple malignancies. Through blockade of key immune regulators including cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), programmed cell …